JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.00739-06v1
80/21/10497    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomita, M.
Right arrow Articles by Mori, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomita, M.
Right arrow Articles by Mori, N.

 Previous Article  |  Next Article 

Journal of Virology, November 2006, p. 10497-10505, Vol. 80, No. 21
0022-538X/06/$08.00+0     doi:10.1128/JVI.00739-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Human T-Cell Leukemia Virus Type 1 Tax Dysregulates ß-Catenin Signaling{triangledown}

Mariko Tomita,1 Akira Kikuchi,3 Tetsu Akiyama,4 Yuetsu Tanaka,2 and Naoki Mori1*

Division of Molecular Virology and Oncology, Graduate School of Medicine,1 Division of Immunology, Faculty of Medicine, University of the Ryukyus, Nishihara, Okinawa, Japan,2 Department of Biochemistry, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan,3 Laboratory of Molecular and Genetic Information, Institute for Molecular and Cellular Biosciences, University of Tokyo, Tokyo, Japan4

Received 11 April 2006/ Accepted 8 August 2006


   ABSTRACT
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Dysregulation of ß-catenin signaling has been implicated in the malignant transformation of cells. However, the role of ß-catenin in the human T-cell leukemia virus type 1 (HTLV-1)-induced transformation of T cells is unknown. Here we found that ß-catenin protein was overexpressed in the nucleus and that ß-catenin-dependent transcription was significantly enhanced in Tax-positive HTLV-1-infected T-cell lines compared to that in Tax-negative HTLV-1-infected T-cell lines. Transfection with ß-catenin-specific small interfering RNA inhibited the growth of the Tax-positive HTLV-1-infected T-cell line HUT-102. Transient transfection of Tax appeared to enhance ß-catenin-dependent transcription by stabilizing the ß-catenin protein via activation of the cyclic AMP (cAMP) response element-binding protein. HTLV-1-infected T-cell lines overexpressing ß-catenin also showed increased Akt activity via Tax activation of the cAMP response element-binding protein, resulting in the phosphorylation and inactivation of glycogen synthase kinase 3ß, which phosphorylates ß-catenin for ubiquitination. The phosphatidylinositol 3-kinase inhibitor LY294002 reduced ß-catenin expression in Tax-positive T-cell lines, and inactivation of glycogen synthase kinase 3ß by lithium chloride restored ß-catenin expression in Tax-negative T-cell lines. Finally, we showed that dominant-negative Akt inhibited Tax-induced ß-catenin-dependent transcription. These results indicate that Tax activates ß-catenin through the Akt signaling pathway. Our findings suggest that activation of ß-catenin by Tax may be important in the transformation of T cells by HTLV-1 infection.


   INTRODUCTION
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Adult T-cell leukemia (ATL) is an aggressive and usually fatal hematological malignancy that is etiologically linked to infection with human T-cell leukemia virus type 1 (HTLV-1) (14, 33, 43). Conventional chemotherapeutic drugs used for the treatment of patients with ATL have yielded only a limited improvement in prognosis (41). Currently, the molecular mechanism of malignant transformation by HTLV-1 remains undefined. Expression of the virally encoded Tax protein appears to be a critical event during the leukemogenesis of ATL. Tax is a transcriptional activator that modulates the expression of HTLV-1 long terminal repeats (LTRs) and the transcription of many cellular genes. Tax can immortalize primary human T cells derived from peripheral blood or cord blood (11, 12) and induce tumors in transgenic mice (29), probably by activating a variety of proteins, including transcription factors such as cyclic AMP response element-binding protein (CREB), serum-responsive factor, and NF-{kappa}B (10).

ß-Catenin is a multifunctional protein that participates in both cell-cell adhesion and the transcription of T-cell transcription factor (Tcf)/lymphoid enhancer binding factor (Lef) target genes. ß-Catenin levels are regulated posttranslationally by the Wnt signaling pathway. In the absence of secreted Wnt glycoprotein ligands, the modular axin protein provides a scaffold for the binding of glycogen synthase kinase 3ß (GSK-3ß), adenomatous polyposis coli (APC) protein, and ß-catenin. This facilitates the phosphorylation of ß-catenin by GSK-3ß, allowing phosphorylated ß-catenin to be ubiquitinated for rapid degradation by the proteasome (34). Mutations in APC, ß-catenin, or axin increase the steady-state level of ß-catenin, and many cancers, including colorectal cancer, result from hyperactivity of the Wnt/ß-catenin signaling pathway due to the constitutive ß-catenin-mediated transactivation of Tcf-dependent genes (34). Thus, aberrant activation of ß-catenin has major oncogenic effects (9, 31). Accordingly, disruption of this signaling pathway holds promise for the development of new anticancer drugs.

ß-Catenin is highly expressed in several leukemic cell lines (4). In B-cell chronic lymphocytic leukemia, Wnt3, Wnt5b, Wnt6, Wnt10a, Wnt14, and Wnt16, as well as the Wnt receptor Frizzled 3, are highly expressed, resulting in the activation of ß-catenin-mediated transcription and an enhanced survival of chronic lymphocytic leukemia lymphocytes (22). These results suggested that ß-catenin is associated not only with epithelial cancer but also with leukemia and lymphoma. However, neither the expression of ß-catenin in HTLV-1-infected T cells nor the function of ß-catenin in leukemogenesis induced by HTLV-1 has been elucidated. The goals of this study were to determine the status of ß-catenin signaling in HTLV-1-infected T cells and to elucidate the molecular activation of this signaling pathway.


   MATERIALS AND METHODS
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Reagents. The proteasome inhibitor N-acetyl-Leu-Leu-norleucinal (LLnL) and the phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 were purchased from Calbiochem (San Diego, CA). Cycloheximide and lithium chloride were obtained from Sigma-Aldrich (St. Louis, MO).

Antibodies. Anti-ß-catenin and anti-GSK-3ß antibodies were purchased from BD Transduction Laboratories (San Jose, CA). An anti-actin antibody was obtained from NeoMarkers (Fremont, CA). An antibody to Tax (Lt-4) was described previously (40). Anti-Akt, anti-phosphorylated Akt (Ser473), and anti-phospho-GSK-3ß (Ser9) antibodies were purchased from Cell Signaling Technology (Beverly, MA). Anti-nucleolin and anti-I{kappa}B{alpha} antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Horseradish peroxidase-conjugated anti-mouse and anti-rabbit immunoglobulin G antibodies for Western blotting were purchased from Amersham Biosciences (Piscataway, NJ).

Cell culture. The HTLV-1-infected T-cell lines MT-2 (27), SLB-1 (20), HUT-102 (33), MT-1 (26), TL-OmI (39), and ED-40515(–) (23) were maintained in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum, 50 U/ml penicillin, and 50 µg/ml streptomycin (Sigma-Aldrich) at 37°C in 5% CO2. MT-2 and SLB-1 are HTLV-1-transformed T-cell lines which were established by an in vitro coculture protocol. MT-1, TL-OmI, and ED-40515(–) are leukemic T-cell lines derived from patients with ATL. HUT-102 was established from a patient with ATL, but its clonal origin is unclear. HeLa (human cervix adenocarcinoma cell line) cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum, 50 U/ml penicillin, and 50 µg/ml streptomycin at 37°C in 5% CO2.

Plasmids. A ß-catenin expression plasmid (pCGN/ß-catenin) and a human Tcf-4 expression plasmid (pEF-BOS HA/Tcf-4E) were described previously (17, 18). The pGL3-OT and pGL3-OF reporter plasmids (37) were kindly provided by B. Vogelstein (The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD). pGL3-OT and pGL3-OF contain three copies of the Tcf site (5'-AGATCAAAGG-3') and a mutant sequence (5'-AGGCCAAAGG-3'), respectively, upstream of the c-fos promoter and the luciferase open reading frame. An HTLV-1 LTR luciferase reporter plasmid (LTR-Luc), which contains the HindIII fragment from the HTLV-1 LTR, was kindly supplied by I. Futsuki (Nagasaki University School of Medicine, Nagasaki, Japan). An NF-{kappa}B reporter plasmid ({kappa}B-Luc) containing five tandem repeats of an NF-{kappa}B binding site from the interleukin-2 receptor {alpha} chain gene was kindly provided by J. Fujisawa (Kansai Medical University, Osaka, Japan). A series of expression vectors for Tax (Tax WT) and mutants thereof (Tax M22, Tax 703, and Tax K88A) was described previously (13, 24). An expression plasmid for dominant-negative CREB (pCMV-KCREB) was purchased from BD Biosciences Clontech (Mountain View, CA). A dominant-negative Akt expression plasmid (pCMV5-K169A, T308A, S473A-Akt) has Lys-169-, Thr-308-, and Ser-473-to-Ala mutations and was kindly provided by D. Alessi (University of Dundee, Dundee, United Kingdom).

Western blot analysis. Cells were lysed in sodium dodecyl sulfate (SDS) sample buffer containing 62.5 mM Tris-HCl (pH 6.8), 2% (wt/vol) SDS, 10% glycerol, 6% 2-mercaptoethanol, and 0.01% bromophenol blue. Nuclear and cytoplasmic extracts were prepared by using a nuclear extraction kit (Active Motif, Carlsbad, CA) according to the manufacturer's instructions. The lysates were resolved by electrophoresis on polyacrylamide gels and then electroblotted onto polyvinylidene difluoride membranes (Millipore, Billerica, MA). Membranes were incubated with the appropriate primary antibody, as indicated, overnight at 4°C. After being washed, the blots were exposed to the appropriate secondary antibody conjugated with horseradish peroxidase for 1 h at room temperature. The reaction products were visualized using enhanced chemiluminescence reagent (Amersham Biosciences) according to the manufacturer's instructions.

Transfection and reporter assay. HeLa cells were transfected using Lipofectamine reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's protocols. HTLV-1-infected T-cell lines were transfected using a previously described DEAE-dextran method (30). In brief, 1 x 107 cells were incubated for 30 min at room temperature with 2.2 ml of transfection solution containing plasmid DNA and 100 µg of DEAE-dextran (Amersham Biosciences) in RPMI 1640 serum-free medium. Cells were then rinsed with 5 U/ml heparin (Wako, Osaka, Japan) in RPMI 1640 and incubated in complete medium for 48 h. Cells were transiently transfected with the indicated effecter plasmids and luciferase reporter constructs. In all cases, the reference plasmid phRL-TK, which contains the Renilla luciferase gene under the control of the herpes simplex virus thymidine kinase promoter, was cotransfected to correct for transfection efficiency. Luciferase assays were performed by using a dual-luciferase reporter system (Promega, Madison, WI) in which relative luciferase activities are calculated by normalizing transfection efficiencies according to the Renilla luciferase activity.

siRNA. To repress ß-catenin, a predesigned double-stranded small interfering RNA (siRNA) (siGENOME SMARTpool CTNNB1; Dharmacon, Inc., Lafayette, CO) was used. A siCONTROL non-targeting siRNA pool (Dharmacon, Inc.) was used as a negative control. siRNAs were transfected into HUT-102 cells with a Nucleofector device (program T-20) and a Cell Line Nucleofector kit V (Amaxa, Inc., Cologne, Germany). Transfected cells were incubated for 12 h, seeded into 24-well plates at 5 x 104 viable cells per well, and incubated for the indicated times. The number of viable cells was determined every 24 h by counting trypan blue-excluding cells in a hemocytometer.

Reverse transcriptase PCR (RT-PCR). Total cellular RNA was extracted from cells by the use of TRIzol reagent (Invitrogen) as described by the supplier. First-strand cDNAs were synthesized using an RNA-PCR kit (Takara Bio, Shiga, Japan) with random primers. Thereafter, cDNAs were amplified for ß-catenin, Tax, and ß-actin. The oligonucleotide primers used were as follows: for ß-catenin, 5'-TGATGGAGTTGGACATGGCCATGG-3'(sense) and 5'-CAGACACCATCTGAGGAGAACGCA-3'(antisense); for Tax, 5'-CCCACTTCCCAGGGTTTGGACAGA-3'(sense) and 5'-CTGTAGAGCTGAGCCGATAACGCG-3'(antisense); and for ß-actin, 5'-GTGGGGCGCCCCAGGCACCA-3'(sense) and 5'-CTCCTTAATGTCACGCACGATTTC-3'(antisense). Product sizes were 570 bp for ß-catenin, 203 bp for Tax, and 548 bp for ß-actin. The amplification programs were as follows: for ß-catenin, 30 cycles of denaturing at 94°C for 1 min, an annealing step at 60°C for 40 s, and an extension step at 72°C for 50 s; for Tax, 30 cycles of denaturing at 94°C for 30 s, an annealing step at 60°C for 30 s, and an extension step at 72°C for 90 s; and for ß-actin, 28 cycles of denaturing at 94°C for 30 s, an annealing step at 60°C for 30 s, and an extension step at 72°C for 90 s. The PCR products were fractionated in 2% agarose gels and visualized by ethidium bromide staining.

In vitro Akt kinase assay. The Akt kinase assay was performed using an Akt kinase assay kit (Cell Signaling Technology) according to the protocol recommended by the manufacturer. Briefly, the cells were washed with phosphate-buffered saline, and 200 µl of lysis buffer (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium PPi, 1 mM ß-glycerol phosphate, 1 mM Na3VO4, 1 mM phenylmethylsulfonyl fluoride, and 1 mM leupeptin) was added to the cells for 10 min. Lysates were immunoprecipitated for 2 h at 4°C with anti-Akt antibody. The immunoprecipitates were washed with lysis buffer and kinase buffer (25 mM Tris-HCl [pH 7.5], 5 mM ß-glycerol phosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4, and 10 mM MgCl2). Kinase reactions were performed for 30 min at 30°C in kinase buffer supplemented with 200 µM ATP and 1 µg GSK-3{alpha}/ß fusion protein. The samples were loaded into a 12% acrylamide gel. Phosphorylation of GSK-3{alpha}/ß was measured by Western blotting with anti-phospho-GSK-3{alpha}/ß (Ser21/9) antibody.


   RESULTS
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Overexpression of ß-catenin in Tax-positive HTLV-1-infected T-cell lines. We first analyzed ß-catenin expression in six HTLV-1-infected T-cell lines. The ß-catenin protein was highly expressed in three of the lines, namely, MT-2, SLB-1, and HUT-102, whereas only weak expression was detected in the three ATL-derived T-cell lines, i.e., MT-1, TL-OmI, and ED-40515(–) (Fig. 1A, top panel). Although the MT-2 cell lysates showed two Tax-immunoreactive bands, consistent with the 40-kDa Tax protein and a 69-kDa fusion between the envelope and the Tax coding sequence reported previously (15), Tax protein levels were similar in the three HTLV-1-infected T-cell lines expressing high levels of ß-catenin protein. In contrast, Tax was hardly detectable in the three ATL-derived T-cell lines, which expressed low levels of ß-catenin (Fig. 1A, middle panel). No ß-catenin protein was detected in a sample of normal peripheral blood mononuclear cells (data not shown). To determine the cellular distribution of ß-catenin, nuclear and cytoplasmic cell fractions from all cell lines were analyzed by Western blotting. ß-Catenin was most abundant in the nuclear fractions of the Tax-positive HTLV-1-infected T-cell lines, while the Tax-negative cells showed relatively smaller amounts of nuclear ß-catenin protein than of the cytoplasmic pool (Fig. 1B).


Figure 1
View larger version (24K):
[in this window]
[in a new window]
  		FIG. 1. ß-Catenin is activated in Tax-positive HTLV-1-infected T cells. (A) Overexpression of ß-catenin in a Tax-positive HTLV-1-infected T-cell line. Total cell lysates were resolved by SDS-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes for probing with anti-ß-catenin and anti-Tax antibodies. The arrow indicates the Tax protein, and the arrowhead indicates a fusion protein between the envelope and the Tax coding sequence. Actin was included as a loading control. (B) Western blot of nuclear (N) and cytoplasmic (C) extracts from HTLV-1-infected T-cell lines with anti-ß-catenin antibody. ß-Catenin accumulated in the nuclei of Tax-positive HTLV-1-infected T cells. Nucleolin and I{kappa}B{alpha} were used as markers of nuclear and cytoplasmic integrity, respectively. (C) Enhanced ß-catenin/Tcf transcriptional activity in Tax-positive HTLV-1-infected T-cell lines. Cells were transfected with 0.1 µg Tcf-4 expression plasmid and 2 µg luciferase reporter plasmid containing the wild-type (pGL3-OT) or mutant (pGL3-OF) Tcf site. After 48 h, cells were collected, and transcriptional activity was determined by a luciferase assay. Relative luciferase activities were measured in cell extracts and normalized to the Renilla luciferase activity. Luciferase activity is presented as x-fold induction relative to the luciferase activity measured in MT-1 cells. Data represent the means ± standard deviations (SD) for three separate experiments. (D) Proteasome inhibition causes ß-catenin accumulation in Tax-negative HTLV-1-infected T-cell lines. Tax-negative [ED-40515(–)] and Tax-positive (HUT-102) HTLV-1-infected T-cell lines were treated with 20 µM LLnL for the indicated times before collection. Western blots of total protein extracts from the cells were probed with ß-catenin, Tax, and actin antibodies.

 
Enhanced transcriptional activity of ß-catenin in Tax-positive HTLV-1-infected T-cell lines. To investigate whether the nuclear accumulation of ß-catenin in Tax-positive HTLV-1-infected T-cell lines resulted in transcriptional activation of the ß-catenin/Tcf complex, both Tax-positive (MT-2, SLB-1, and HUT-102) and Tax-negative [MT-1 and ED-40515(–)] T-cell lines were transfected with Tcf reporter plasmids containing three copies of the wild-type (pGL3-OT) or mutant (pGL3-OF) Tcf site. The Tax-positive cells showing increased ß-catenin protein in the nucleus showed a higher level of transcriptional activation of pGL3-OT than did the Tax-negative HTLV-1-infected T-cell lines (Fig. 1C). Activation of pGL3-OF was not observed in any cell lines. These results suggested that the accumulation of ß-catenin in the nucleus enhances the transcriptional activity of the ß-catenin/Tcf complex.

Proteasome inhibition causes ß-catenin accumulation in Tax-negative but not in Tax-positive HTLV-1-infected T-cell lines. To determine whether the low level of ß-catenin protein in the Tax-negative HTLV-1-infected T-cell lines was due to proteasomal degradation, we treated the cells with LLnL, a potent proteasome inhibitor, and then again analyzed the expression levels of ß-catenin protein by Western blot analysis (Fig. 1D). In a Tax-negative T-cell line, ED-40515(–), significant accumulation of the ß-catenin protein was detected in the presence of LLnL, in a time-dependent manner. A similar result was obtained for another Tax-negative cell line, MT-1 (data not shown). In contrast, ß-catenin levels were not further increased by LLnL treatment in the Tax-positive HUT-102 or MT-2 cells (data not shown). LLnL treatment did not change the expression level of Tax protein. Therefore, the difference in ß-catenin levels between Tax-positive and Tax-negative HTLV-1-infected T-cell lines is attributable to differential degradation but not to differential expression. These results tempted us to investigate the role of the Tax protein in the activation of ß-catenin signaling.

Suppression of ß-catenin expression inhibited cell growth of Tax-positive HTLV-1-infected T-cell line. To examine the role of ß-catenin in HTLV-1-infected T-cell growth, HUT-102 cells were transfected with ß-catenin siRNA. Cell growth was inhibited in HUT-102 cells transfected with ß-catenin siRNA compared with cells transfected with nontargeting siRNA (Fig. 2A). The suppression of ß-catenin mRNA expression by ß-catenin siRNA was confirmed by RT-PCR (Fig. 2B). These results indicated the specific role of ß-catenin in the growth of Tax-positive HTLV-1-infected T cells.


Figure 2
View larger version (29K):
[in this window]
[in a new window]
  		FIG. 2. Repression of ß-catenin expression suppresses cell growth of HTLV-1-infected T-cell line. (A) HUT-102 cells were transfected with siRNA to repress ß-catenin (+) or with a nontarget siRNA (–). The effect of siRNA on cell growth was examined by counting the viable cell number in triplicate by the trypan blue dye exclusion method. Data are expressed as means ± SD. (B) RT-PCR analysis showing repression of ß-catenin mRNA in HUT-102 cells transfected with ß-catenin siRNA (+) compared to that in cells transfected with a nontargeting siRNA (–) 24, 48, and 72 h after transfection. ß-Actin expression was used as the cDNA loading control.

 
Tax induces the accumulation of ß-catenin protein. To determine whether Tax affects endogenous ß-catenin levels, HeLa cells were transfected with increasing amounts of a wild-type Tax (Tax WT) expression plasmid. Total cell extracts and total RNA from transfected HeLa cells were analyzed for ß-catenin expression by Western blot and RT-PCR analyses, respectively. Increased levels of ß-catenin protein were detected in the presence of Tax, in a dose-dependent manner (Fig. 3A). In contrast, ß-catenin mRNA levels were not changed by Tax (Fig. 3B). Next, to determine the signaling pathway responsible for the Tax-induced ß-catenin protein accumulation, we used three Tax mutant expression plasmids, which have been described previously (13, 24). Tax M22, which has amino acid substitutions at residues 130 and 131, from Thr-Leu to Ser-Ala, effectively activates the cyclic AMP response element (CRE), which mediates the Tax-dependent activation of the HTLV-1 LTR but not of the NF-{kappa}B element. Tax 703 has amino acid substitutions at residues 319 and 320, from Leu-Leu to Arg-Ser, which make it equivalent to mutant M47, and Tax K88A carries a single amino acid substitution at position 88, from Lys to Ala. Tax 703 and Tax K88A activate the NF-{kappa}B element but do not affect the CRE. In the current experiments, Tax M22, but not Tax 703 or Tax K88A, increased the ß-catenin protein level (Fig. 3A). In contrast, ß-catenin mRNA levels were not altered by any of the Tax mutants (Fig. 3B). The expression levels of Tax protein and mRNA were increased independently of the amount of plasmid used (Fig. 3A and B). These results suggested that Tax induces ß-catenin expression at the posttranscriptional level by activation of the CREB signaling pathway.


Figure 3
View larger version (51K):
[in this window]
[in a new window]
  		FIG. 3. Tax induces increased protein levels but does not change mRNA levels for endogenous ß-catenin. HeLa cells were transfected with increasing amounts of wild-type Tax (Tax WT) or Tax mutant (Tax M22, Tax 703, and Tax K88A) expression plasmids. (A) Total cell extracts from transfected HeLa cells were analyzed for ß-catenin and Tax protein expression by Western blot analysis. Actin was used as a loading control. (B) ß-Catenin mRNA expression was evaluated by RT-PCR analysis of transfected HeLa cells. One microgram of total RNA extracted from each transfected HeLa cell sample was used for reverse transcription. PCR was then performed with the primers for ß-catenin, Tax, and ß-actin.

 
Tax stabilizes ß-catenin protein. To elucidate the mechanisms by which Tax induces ß-catenin protein accumulation, we examined the effects of Tax on ß-catenin turnover. HeLa cells were transfected with either empty vector [Tax (–)], wild-type Tax (Tax WT), or mutant Tax (M22, 703, or K88A) expression plasmids. To evaluate the degradation of ß-catenin proteins, we also transfected ß-catenin expression plasmids together with Tax. Cycloheximide (12.5 µg/ml) was added to the cell culture medium 24 h after transfection to block new protein synthesis, and protein extracts were prepared 0, 2, 4, and 6 h after the addition of cycloheximide. Western blotting showed that ß-catenin was rapidly degraded in HeLa cells transfected with empty vector [Tax (–)], whereas ß-catenin levels remained stable in the presence of Tax WT throughout the 6-h chase period (Fig. 4). The increased ß-catenin levels induced by Tax are therefore a consequence of protein stabilization. Expression of the mutant protein Tax M22 also stabilized ß-catenin protein levels for 6 h, whereas cells transfected with the 703 and K88A mutants showed reduced levels, as in the controls. These results suggested that the Tax-induced activation of the CREB signaling pathway stabilizes the cellular levels of ß-catenin.


Figure 4
View larger version (44K):
[in this window]
[in a new window]
  		FIG. 4. The half-life of ß-catenin is extended in HeLa cells transfected with Tax. HeLa cells were transfected with 0.5 µg ß-catenin and 1 µg empty vector (–) or a wild-type Tax (Tax WT) or Tax mutant (M22, 703, or K88A) expression plasmid. Transfected HeLa cells were incubated with 12.5 µg/ml cycloheximide (CHX) to block new protein synthesis. Extracts were prepared at the indicated times after the cycloheximide block and then were analyzed for ß-catenin and Tax protein expression by Western blotting. Actin was included as a loading control.

 
Tax enhances ß-catenin/Tcf transcriptional activity. We next asked whether the stabilization of ß-catenin protein by Tax affected ß-catenin/Tcf transcriptional activity (Fig. 5A). In a transient transfection assay using pGL3-OT as a reporter, the expression of Tax WT or ß-catenin alone in HeLa cells activated the reporter. The combination of ß-catenin and Tax WT had an even greater effect. No significant responses were seen with the mutant reporter (pGL3-OF) (data not shown). These results suggested that ß-catenin and Tax activate Tcf synergistically. We also tested the effects of Tax mutants on ß-catenin/Tcf transcriptional activity. As with ß-catenin protein stabilization, Tax M22, but not the 703 or K88A mutant, activated the pGL3-OT reporter and acted synergistically with ß-catenin. None of the Tax mutants affected the pGL3-OF reporter activity (data not shown). Together, these sets of experiments suggest that the stabilization of ß-catenin protein by Tax enhances the transcriptional activity of ß-catenin/Tcf and that this effect of Tax is mediated via the CREB signaling pathway.


Figure 5
View larger version (23K):
[in this window]
[in a new window]
  		FIG. 5. Tax enhances transcriptional activity of ß-catenin/Tcf through activation of the CREB signaling pathway. (A) HeLa cells were transfected with 0.1 µg Tcf-4 expression plasmid and 2 µg luciferase reporter plasmid containing the wild-type (pGL3-OT) Tcf site in the presence (+) or absence (–) of 1 µg Tax WT or a Tax mutant (M22, 703, or K88A) and 0.5 µg ß-catenin, as indicated. (B) HeLa cells were transfected with 0.5 µg ß-catenin, 0.1 µg Tcf-4 expression plasmid, and 2 µg luciferase reporter plasmid containing a wild-type (pGL3-OT) or mutant (pGL3-OF) Tcf site in the presence (+) or absence (–) of 1 µg Tax WT and increasing amounts of dominant-negative CREB (KCREB) expression plasmid (0, 0.1, 0.5, and 1 µg), as indicated. (C) HeLa cells were transfected with 0.1 µg LTR-Luc or {kappa}B-Luc reporter plasmid, together with 0.5 µg Tax WT and increasing amounts of KCREB (0, 0.1, 0.5, and 1 µg), as indicated. After 48 h, the cells were collected, and transcriptional activity was determined by a luciferase assay. Relative luciferase activities were measured in cell extracts, normalized to the Renilla luciferase activity, and presented as x-fold induction relative to the basal level measured in cells transfected with Tcf-4 and reporter plasmids without Tax or ß-catenin (A), with ß-catenin, Tcf-4, and reporter plasmids (B), or with reporter plasmids alone without Tax or KCREB (C). Data represent means ± SD for three separate experiments.

 
Dominant-negative CREB restores the Tax-induced activation of ß-catenin/Tcf transcriptional activity. To further ascertain the biological role of CREB in transcriptional activation of the ß-catenin/Tcf complex by Tax, HeLa cells were transfected with KCREB, a dominant-negative version of CREB. The pCMV-KCREB construct encodes a CREB protein with Arg 287 mutated to Leu in the DNA-binding domain. KCREB acts as a dominant-negative repressor of wild-type CREB, blocking its binding to CRE. HeLa cells were transfected with ß-catenin, Tcf-4, and the pGL3-OT or pGL3-OF reporter plasmid in the presence or absence of Tax WT and increasing amounts of KCREB (Fig. 5B). KCREB inhibited the Tax-induced activation of pGL3-OT luciferase activity in a dose-dependent manner, whereas no significant responses were seen with the pGL3-OF reporter plasmid. An HTLV-1 LTR luciferase reporter (LTR-Luc) containing three unique CRE-containing 21-bp repeats was used to confirm the effects of KCREB on the action of Tax. HeLa cells were transfected with LTR-Luc or a {kappa}B-Luc reporter plasmid in the presence or absence of Tax WT and increasing amounts of KCREB. Tax could activate gene expression from both the HTLV-1 LTR and NF-{kappa}B reporters. However, KCREB inhibited only HTLV-1 LTR transcriptional activity, not NF-{kappa}B transcriptional activity (Fig. 5C), indicating that KCREB blocks Tax-induced activation of the CREB, but not NF-{kappa}B, pathway. These results indicated that Tax activates the ß-catenin/Tcf transcriptional activity through the activation of CREB signaling.

Accumulation of ß-catenin protein correlates with activation of Akt signaling by Tax. The activation of Akt signaling has been associated with an accumulation of ß-catenin (36). Akt activation can be mediated by the activation of PI3K, and Tax activates the PI3K pathway (21). In addition, Jeong and colleagues recently showed that Akt is activated in HTLV-1-transformed T-cell lines and that Tax activates Akt in these cells (16). To determine whether Akt activation is associated with the stabilization of ß-catenin in the HTLV-1-infected T-cell lines, we examined the phosphorylation status of Akt and the in vitro Akt kinase activity relative to ß-catenin protein expression (Fig. 6A). Phosphorylated Akt was strongly detected in the three Tax-positive HTLV-1-infected T-cell lines (MT-2, SLB-1, and HUT-102), whereas only weak expression of this phosphorylated protein was detected in the Tax-negative T-cell lines [MT-1, TL-OmI, and ED-40515(–)]. Total Akt protein was similarly expressed in all cell lines. The in vitro Akt kinase activity was also higher in Tax-positive T-cell lines than in those that were Tax negative. Next, to examine how Tax regulates Akt signaling activity, Tax WT or a Tax mutant (M22, 703, or K88A) was expressed in HeLa cells together with Akt. The activation of Akt was assessed by Western blot analysis of phosphorylated Akt and GSK-3ß, which is a downstream target of Akt kinase. Tax WT and Tax M22 increased the phosphorylation of Akt and GSK-3ß, while Tax 703 and Tax K88A induced no phosphorylation of either protein. Total Akt and GSK-3ß protein levels were not affected by any of the expressed plasmids. These results indicated that Tax also activates Akt signaling via activation of the CREB pathway. The expression of ß-catenin protein was also increased by Tax WT and Tax M22, but not by the 703 and K88A mutants (Fig. 3), suggesting that the accumulation of ß-catenin protein might be mediated by activation of the Akt signaling pathway, resulting in inactivation of GSK-3ß.


Figure 6
View larger version (56K):
[in this window]
[in a new window]
  		FIG. 6. Tax enhances ß-catenin/Tcf transcriptional activity through the Akt signaling pathway. Total lysates of HTLV-1-infected T-cell lines (A), of HeLa cells transfected with 1 µg Akt and 1 µg Tax WT or a Tax mutant (M22, 703, or K88A), as indicated (B), of MT-2 cells treated with the PI3K inhibitor LY294002 (20 µM) for the indicated periods (C), or of MT-1 and MT-2 cells treated with 10 mM lithium chloride (LiCl) (GSK-3ß inhibitor) for 24 h (D) were resolved by SDS-polyacrylamide gel electrophoresis, and Western blots were probed with anti-phosphorylated Akt (Ser473 [p-Akt]), anti-Akt, anti-phosphorylated GSK-3ß (Ser9 [p-GSK-3ß]), anti-GSK-3ß, anti-Tax, and anti-actin antibodies, as indicated. To assess Akt kinase activity, in vitro Akt kinase assays with GSK-3{alpha}/ß as a substrate were performed. Phosphorylated GSK-3{alpha}/ß was detected with anti-phospho-GSK-3{alpha}/ß (Ser21/9) antibody (bottom rows in panels A and B). (E) HeLa cells were transfected with 0.1 µg Tcf-4 expression plasmid and 2 µg luciferase reporter plasmid containing the wild-type (pGL3-OT) or mutant (pGL3-OF) Tcf site together with 1 µg Tax and 1 µg of either wild-type Akt (Akt-WT) or dominant-negative Akt (Akt-DN) expression plasmid, as indicated. After 48 h, the cells were collected, and transcriptional activities were determined by a luciferase assay. Relative luciferase activities were measured in cell extracts, normalized to the Renilla luciferase activity, and presented as x-fold induction relative to the basal level measured in cells transfected with Tcf-4 and reporter plasmids without Tax or Akt. Data represent means ± SD for three separate experiments.

 
Accumulation of ß-catenin protein is regulated by the PI3K/Akt signaling pathway in HTLV-1-infected T-cell lines. To examine the role of Akt signaling in the accumulation of ß-catenin in HTLV-1-infected T cells, Tax-positive MT-2 cells were treated with the PI3K inhibitor LY294002 (Fig. 6C). In the presence of 20 µM LY294002, ß-catenin expression was significantly reduced, in a time-dependent manner. Phosphorylation of both Akt and GSK-3ß was inhibited by LY294002, whereas the total levels of both proteins were unaffected. The expression of Tax was not changed by LY294002 treatment. These data suggested that overexpression of ß-catenin in MT-2 cells is mediated by constitutive activation of PI3K/Akt signaling. Next, to elucidate the role of GSK-3ß activity in regulating ß-catenin expression, we used lithium chloride, which acts as a noncompetitive inhibitor of GSK-3ß (19) (Fig. 6D), and observed an induction of ß-catenin protein expression in Tax-negative MT-1 cells, whose GSK-3ß proteins are active (dephosphorylated at Ser9). Similar results were obtained with another Tax-negative cell line [ED-40515(–) (data not shown)]. In contrast, ß-catenin levels were not increased after lithium chloride treatment in the Tax-positive MT-2 cells (Fig. 6D) or HUT-102 cells (data not shown), whose GSK-3ß proteins are already inactive (phosphorylated at Ser9). The expression of Tax itself was not changed by lithium chloride treatment. These results indicated that LiCl increases ß-catenin levels in cell lines which have activated GSK-3ß but not in those which have inactive GSK-3ß, suggesting that the difference in ß-catenin levels between Tax-positive and Tax-negative HTLV-1-infected T-cell lines is attributable to the differential activity of GSK-3ß.

Dominant-negative Akt inhibits Tax-induced ß-catenin/Tcf transcriptional activity. To further study the enhancive effect of Tax and Akt activation on ß-catenin/Tcf-mediated transcription, we used wild-type (Akt-WT) and dominant-negative mutant (Akt-DN) Akt expression plasmids to directly examine the involvement of Akt in Tax-induced ß-catenin/Tcf transcription (Fig. 6E). Akt-WT enhanced pGL3-OT activity induced by Tax, while Akt-DN suppressed the Tax-induced pGL3-OT activity. Both the wild-type and dominant-negative mutant Akt plasmids did not affect pGL3-OF activity. These data demonstrated that ß-catenin/Tcf transcriptional activation by Tax is mediated via the Akt signaling pathway.


   DISCUSSION
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
In this study, we observed an accumulation of nuclear ß-catenin protein and an enhanced transcriptional activity of ß-catenin/Tcf in Tax-positive HTLV-1-infected T-cell lines but not in those that were Tax negative. Proteasome inhibition restored ß-catenin protein expression in Tax-negative, but not Tax-positive, T-cell lines, suggesting that Tax might stabilize the ß-catenin protein by inhibiting protein degradation. Transfection with ß-catenin siRNA inhibited cell growth of HUT-102 cells, a Tax-positive HTLV-1-infected T-cell line. We further demonstrated that HTLV-1 Tax activates ß-catenin/Tcf-dependent transcription by stabilizing the ß-catenin protein through the CREB signaling pathway in Tax-transfected HeLa cells. Furthermore, transient expression of Tax in HeLa cells led to the CREB-dependent phosphorylation and activation of Akt and the subsequent phosphorylation and inactivation of the Akt target, GSK-3ß. In turn, dominant-negative Akt inhibited the Tax-induced ß-catenin/Tcf transcriptional activity, and upon inactivation of the negative Wnt signaling regulator, GSK-3ß, ß-catenin was stabilized to therefore activate ß-catenin/Tcf-dependent transcription (Fig. 7). Treatment of Tax-positive T-cell lines with a PI3K inhibitor and inactivation of GSK-3ß in Tax-negative T-cell lines implicated GSK-3ß inactivation in the process of ß-catenin accumulation in HTLV-1-infected T cells.


Figure 7
View larger version (22K):
[in this window]
[in a new window]
  		FIG. 7. Schematic representation of the effects of Tax on the ß-catenin signaling pathway. Tax activates PI3K/Akt through activating the CREB signaling pathway, although the mechanism of this activation remains to be elucidated. Akt subsequently phosphorylates and inhibits GSK-3ß, a negative regulator of ß-catenin. Inactivation of GSK-3ß prevents proteasomal degradation of ß-catenin, and in turn, activated ß-catenin can translocate to the nucleus and bind to the transcription factor Tcf.

 
The Akt signaling pathway is important for the survival and growth of numerous types of cancer cells. Previous studies showed that Tax induces PI3K signaling activation and that this activation is associated with transformation of Rat-1 fibroblast cells stably expressing Tax (21). More recently, Jeong and colleagues demonstrated that Akt signaling is activated in HTLV-1-transformed cells and that Tax can activate this signaling pathway by inducing Akt phosphorylation (16). These observations indicated that Tax-induced Akt signaling activation plays an important role in the transformation of HTLV-1-infected cells. Consistent with these findings, we found here that phosphorylation and activation of Akt were associated with Tax expression in HTLV-1-infected T-cell lines and that Tax induced Akt activation in transfected HeLa cells. Moreover, we demonstrated, for the first time, an association between the activation of CREB signaling by Tax and the Tax-induced activation of Akt. Recently, silencing of CREB gene expression by RNA interference decreased the phosphorylation of Akt induced by forskolin stimulation (25). However, it remains unclear exactly how Tax activates Akt through the CREB signaling pathway, and future studies need to address this issue. During preparation of this article, a study showing Tax-mediated Akt activation was published by Kuan-Teh Jeang's lab (32). They concluded that Tax-mediated Akt activation depended on the ability of Tax to interact with the p85{alpha} subunit of PI3K but not on the CREB-activating activity of Tax. Moreover, they found that a Tax mutant, Tax M22, could not activate Akt in mouse embryonic fibroblasts (MEFs). In the present study, we demonstrated that Tax M22 could activate Akt in HeLa cells. However, they reported that a Tax mutant with disrupted NF-{kappa}B activation, Tax S258A, could activate Akt in MEFs. The precise reason for these differences is not clear, but we cannot exclude the possibility that these differences could be attributable to the differences in the cell lines which were used for the Akt assay. We used HeLa cells, which are highly transformed, but primary cells (such as MEFs) were used in Jeang's study. Further analysis is needed to elucidate whether the differences between the two studies are due to the differences in the cells which were used for the experiments.

Recently, Yang et al. demonstrated that the APC gene promoter region was methylated in some cases of acute or chronic ATL (42). Epigenetic modifications can affect gene expression and contribute to the pathogenesis of tumor formation and growth. Methylation of CpG islands within tumor suppressor genes is an important oncogenic mechanism in certain cancers, including hematological malignancies. Yang's results suggested that a loss of APC gene expression by methylation of its promoter might lead to ß-catenin stabilization. However, we observed normal expression of the APC protein in all HTLV-1-infected T-cell lines tested here (data not shown). Therefore, diminished APC function by hypermethylation may not be a common mechanism for inducing ß-catenin activation in HTLV-1-infected T cells.

In this study, we demonstrated that the CREB-activating activity of Tax is important for Akt and ß-catenin activation, which enhances cell growth and survival. Previous studies reported that the CREB pathway is required for the clonal expansion of CD4+ and CD8+ T cells (1), and a Tax mutant which is active for CREB but deficient in NF-{kappa}B signaling can immortalize human primary T lymphocytes (35). Consisting with our findings, these results of previous studies indicated that the Tax-activated CREB pathway plays an important role in the permanent growth and immortalization of human T lymphocytes.

What is the specific role of ß-catenin in Tax-mediated biology? To answer this question, we demonstrated that transfection with ß-catenin siRNA inhibited the growth of the HTLV-1-infected T-cell line HUT-102, which expresses high levels of ß-catenin protein. Our results are consistent with a previous study showing that the growth of HUT-102 cells was inhibited by overexpression of a dominant-negative ß-catenin or dominant-negative Tcf expression plasmid (4). These results implicated ß-catenin in the cell growth of HTLV-1-infected T cells. Enhanced expression of the ß-catenin-regulating genes, such as cyclin D1 and c-myc, which regulate cell cycle progression and apoptosis, has been observed in Tax-positive HTLV-1-infected T-cell lines (data not shown). It could thus be proposed that overexpression of these proteins might result in malignant cell growth of HTLV-1-infected T cells. Importantly, ß-catenin expression was not increased in peripheral blood mononuclear cells from ATL patients (data not shown). Because the expression of Tax was not detected in these ATL cells, overexpression of ß-catenin may depend on Tax expression and may not be necessary to maintain the malignant phenotype in the late (Tax-independent) stage of ATL.

The Wnt/ß-catenin signaling pathway has been identified as a common target for perturbation by viruses, as demonstrated by the following examples from the literature. Similar to the effect of Tax on ß-catenin signaling, Epstein-Barr virus encodes latent membrane protein 2A, which activates PI3K and Akt, resulting in GSK-3ß inactivation and ß-catenin stabilization (28). The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus binds to GSK-3ß and sequesters it in the nucleus, preventing ß-catenin phosphorylation (6, 7). The large T antigen of JC virus, a human polyomavirus, interacts with ß-catenin, stabilizing it and promoting its nuclear accumulation as well as activating a c-myc promoter (5, 8). The Vpu protein of human immunodeficiency virus type 1 binds to the ß-transducin repeat-containing protein and blocks the ubiquitination and proteasomal degradation of ß-catenin (2). Hepatitis B virus X protein achieves ß-catenin stabilization by suppressing GSK-3ß activity in an Src kinase-dependent manner (3). Finally, hepatitis C virus NS5A activates PI3K, resulting in stabilization of ß-catenin (38). Therefore, the Wnt pathway is targeted by many different oncogenic viral proteins via distinct mechanisms, indicating the importance of this pathway in the genesis of virus-associated tumors.

In summary, the data presented here show that ß-catenin signaling is activated in Tax-positive HTLV-1-infected T-cell lines. Activation of the Akt pathway by Tax induced the inactivation of GSK-3ß, leading to stabilization of the ß-catenin protein. The increased ß-catenin expression induced by Tax was followed by an upregulation of ß-catenin-induced transcriptional activity, and the activation of ß-catenin through the Akt signaling pathway was mediated by the activation of CREB signaling via Tax activation. Together, our results implicate an important role for Tax in the activation of the ß-catenin signaling pathway and thereby in the transformation of T lymphocytes by HTLV-1 infection.


   ACKNOWLEDGMENTS
 
We thank M. Maeda for providing the ED-40515(–) cell line; the Fujisaki Cell Center, Hayashibara Biomedical Laboratories (Okayama, Japan), for providing the HUT-102 and MT-1 cell lines; B. Vogelstein for providing pGL3-OT and pGL3-OF; J. Fujisawa for providing {kappa}B-Luc; I. Futsuki for providing LTR-Luc; K. Matsumoto for providing Tax WT, Tax M22, and Tax 703; C.-Z. Giam for providing Tax K88A; and D. Alessi for the wild-type and dominant-negative Akt expression plasmids. We also acknowledge all members of our laboratories for their helpful comments and collaborations.

This work was supported in part by grants-in-aid 16590951 and 17790654 from the Japan Society for the Promotion of Science and grant-in-aid 16017289 from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Takeda Science Foundation, the Uehara Memorial Foundation, and the Foundation for Promotion of Cancer Research in Japan.


   FOOTNOTES
 
* Corresponding author. Mailing address: Division of Molecular Virology and Oncology, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa 903-0215, Japan. Phone: 81 (98) 895-1130. Fax: 81 (98) 895-1410. E-mail: n-mori{at}med.u-ryukyu.ac.jp. Back

{triangledown} Published ahead of print on 18 August 2006. Back


   REFERENCES
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Akagi, T., H. Ono, H. Nyunoya, and K. Shimotohno. 1997. Characterization of peripheral blood T-lymphocytes transduced with HTLV-1 Tax mutants with different trans-activating phenotypes.Oncogene 14:2071-2078.[CrossRef][Medline]
  2. Besnard-Guerin, C., N. Belaidouni, I. Lassot, E. Segeral, A. Jobart, C. Marchal, and R. Benarous. 2004. HIV-1 Vpu sequesters ß-transducin repeat-containing protein (ßTrCP) in the cytoplasm and provokes the accumulation of ß-catenin and other SCFßTrCP substrates. J. Biol. Chem. 279:788-795.[Abstract/Free Full Text]
  3. Cha, M. Y., C. M. Kim, Y. M. Park, and W. S. Ryu. 2004. Hepatitis B virus X protein is essential for the activation of Wnt/ß-catenin signaling in hepatoma cells. Hepatology 39:1683-1693.[CrossRef][Medline]
  4. Chung, E. J., S. G. Hwang, P. Nguyen, S. Lee, J. S. Kim, J. W. Kim, P. A. Henkart, D. P. Bottaro, L. Soon, P. Bonvini, S. J. Lee, J. E. Karp, H. J. Oh, J. S. Rubin, and J. B. Trepel. 2002. Regulation of leukemic cell adhesion, proliferation, and survival by ß-catenin. Blood 100:982-990.[Abstract/Free Full Text]
  5. Enam, S., L. Del Valle, C. Lara, D. D. Gan, C. Ortiz-Hidalgo, J. P. Palazzo, and K. Khalili. 2002. Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and ß-catenin. Cancer Res. 62:7093-7101.[Abstract/Free Full Text]
  6. Fujimuro, M., and S. D. Hayward. 2003. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3ß. J. Virol. 77:8019-8030.[Abstract/Free Full Text]
  7. Fujimuro, M., F. Y. Wu, C. ApRhys, H. Kajumbula, D. B. Young, G. S. Hayward, and S. D. Hayward.2003 . A novel viral mechanism for dysregulation of ß-catenin in Kaposi's sarcoma-associated herpesvirus latency.Nat. Med. 9:300-306.[CrossRef][Medline]
  8. Gan, D. D., and K. Khalili. 2004. Interaction between JCV large T-antigen and ß-catenin.Oncogene 23:483-490.[CrossRef][Medline]
  9. Giles, R. H., J. H. van Es, and H. Clevers.2003 . Caught up in a Wnt storm: Wnt signaling in cancer.Biochim. Biophys. Acta 1653:1-24.[Medline]
  10. Grassmann, R., M. Aboud, and K. T. Jeang. 2005. Molecular mechanisms of cellular transformation by HTLV-1 Tax.Oncogene 24:5976-5985.[CrossRef][Medline]
  11. Grassmann, R., S. Berchtold, I. Radant, M. Alt, B. Fleckenstein, J. G. Sodroski, W. A. Haseltine, and U. Ramstedt.1992 . Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture.J. Virol. 66:4570-4575.[Abstract/Free Full Text]
  12. Grassmann, R., C. Dengler, I. Muller-Fleckenstein, B. Fleckenstein, K. McGuire, M. C. Dokhelar, J. G. Sodroski, and W. A. Haseltine. 1989. Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a herpesvirus saimiri vector. Proc. Natl. Acad. Sci. USA 86:3351-3355.[Abstract/Free Full Text]
  13. Harrod, R., Y. Tang, C. Nicot, H. S. Lu, A. Vassilev, Y. Nakatani, and C. Z. Giam. 1998. An exposed KID-like domain in human T-cell lymphotropic virus type 1 Tax is responsible for the recruitment of coactivators CBP/p300. Mol. Cell. Biol. 18:5052-5061.[Abstract/Free Full Text]
  14. Hinuma, Y., K. Nagata, M. Hanaoka, M. Nakai, T. Matsumoto, K. I. Kinoshita, S. Shirakawa, and I. Miyoshi.1981 . Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA 78:6476-6480.[Abstract/Free Full Text]
  15. Jeang, K. T., D. Derse, M. Matocha, and O. Sharma.1997 . Expression status of Tax protein in human T-cell leukemia virus type 1-transformed MT4 cells: recall of MT4 cells distributed by the NIH AIDS Research and Reference Reagent Program.J. Virol. 71:6277-6278.[Medline]
  16. Jeong, S. J., C. A. Pise-Masison, M. F. Radonovich, H. U. Park, and J. N. Brady.2005 . Activated AKT regulates NF-{kappa}B activation, p53 inhibition and cell survival in HTLV-1-transformed cells.Oncogene 24:6719-6728.[CrossRef][Medline]
  17. Kishida, M., S. Hino, T. Michiue, H. Yamamoto, S. Kishida, A. Fukui, M. Asashima, and A. Kikuchi. 2001. Synergistic activation of the Wnt signaling pathway by Dvl and casein kinase I{varepsilon}.J. Biol. Chem. 276:33147-33155.[Abstract/Free Full Text]
  18. Kishida, S., H. Yamamoto, S. Ikeda, M. Kishida, I. Sakamoto, S. Koyama, and A. Kikuchi. 1998. Axin, a negative regulator of the Wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of ß-catenin.J. Biol. Chem. 273:10823-10826.[Abstract/Free Full Text]
  19. Klein, P. S., and D. A. Melton. 1996. A molecular mechanism for the effect of lithium on development.Proc. Natl. Acad. Sci. USA 93:8455-8459.[Abstract/Free Full Text]
  20. Koeffler, H. P., I. S. Chen, and D. W. Golde.1984 . Characterization of a novel HTLV-1nfected cell line.Blood 64:482-490.[Abstract/Free Full Text]
  21. Liu, Y., Y. Wang, M. Yamakuchi, S. Masuda, T. Tokioka, S. Yamaoka, I. Maruyama, and I. Kitajima. 2001. Phosphoinositide-3 kinase-PKB/Akt pathway activation is involved in fibroblast Rat-1 transformation by human T-cell leukemia virus type I Tax.Oncogene 20:2514-2526.[CrossRef][Medline]
  22. Lu, D., Y. Zhao, R. Tawatao, H. B. Cottam, M. Sen, L. M. Leoni, T. J. Kipps, M. Corr, and D. A. Carson. 2004. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 101:3118-3123.[Abstract/Free Full Text]
  23. Maeda, M., A. Shimizu, K. Ikuta, H. Okamoto, M. Kashihara, T. Uchiyama, T. Honjo, and J. Yodoi. 1985. Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement. J. Exp. Med. 162:2169-2174.[Abstract/Free Full Text]
  24. Matsumoto, K., H. Shibata, J. I. Fujisawa, H. Inoue, A. Hakura, T. Tsukahara, and M. Fujii. 1997. Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways. J. Virol. 71:4445-4451.[Abstract]
  25. Misra, U. K., and S. V. Pizzo. 2005. Coordinate regulation of forskolin-induced cellular proliferation in macrophages by protein kinase A/cAMP-response element-binding protein (CREB) and Epac1-Rap1 signaling: effects of silencing CREB gene expression on Akt activation. J. Biol. Chem. 280:38276-38289.[Abstract/Free Full Text]
  26. Miyoshi, I., I. Kubonishi, M. Sumida, S. Hiraki, T. Tsubota, I. Kimura, K. Miyamoto, and J. Sato. 1980. A novel T-cell line derived from adult T-cell leukemia. Jpn. J. Cancer Res. 71:155-156.
  27. Miyoshi, I., I. Kubonishi, S. Yoshimoto, T. Akagi, Y. Ohtsuki, Y. Shiraishi, K. Nagata, and Y. Hinuma. 1981. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 294:770-771.[CrossRef][Medline]
  28. Morrison, J. A., A. J. Klingelhutz, and N. Raab-Traub.2003 . Epstein-Barr virus latent membrane protein 2A activates ß-catenin signaling in epithelial cells.J. Virol. 77:12276-12284.[Abstract/Free Full Text]
  29. Nerenberg, M., S. H. Hinrichs, R. K. Reynolds, G. Khoury, and G. Jay. 1987. The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice.Science 237:1324-1329.[Abstract/Free Full Text]
  30. Ohtani, K., M. Nakamura, S. Saito, T. Noda, Y. Ito, K. Sugamura, and Y. Hinuma. 1987. Identification of two distinct elements in the long terminal repeat of HTLV-1 responsible for maximum gene expression. EMBO J. 6:389-395.[Medline]
  31. Peifer, M., and P. Polakis. 2000. Wnt signaling in oncogenesis and embryogenesis—a look outside the nucleus.Science 287:1606-1609.[Abstract/Free Full Text]
  32. Peloponese, J. M., Jr., and K. T. Jeang. 2006. Role for Akt/protein kinase B and activator protein-1 in cellular proliferation induced by the human T-cell leukemia virus type 1 Tax oncoprotein. J. Biol. Chem. 281:8927-8938.[Abstract/Free Full Text]
  33. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415-7419.[Abstract/Free Full Text]
  34. Polakis, P. 2000. Wnt signaling and cancer. Genes Dev. 14:1837-1851.[Free Full Text]
  35. Rosin, O., C. Koch, I. Schmitt, O. J. Semmes, K. T. Jeang, and R. Grassmann. 1998. A human T-cell leukemia virus Tax variant incapable of activating NF-{kappa}B retains its immortalizing potential for primary T-lymphocytes. J. Biol. Chem. 273:6698-6703.[Abstract/Free Full Text]
  36. Sharma, M., W. W. Chuang, and Z. Sun. 2002. Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3ß inhibition and nuclear ß-catenin accumulation.J. Biol. Chem. 277:30935-30941.[Abstract/Free Full Text]
  37. Shih, I. M., J. Yu, T. C. He, B. Vogelstein, and K. W. Kinzler. 2000. The ß-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression. Cancer Res. 60:1671-1676.[Abstract/Free Full Text]
  38. Street, A., A. Macdonald, C. McCormick, and M. Harris. 2005. Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular ß-catenin and stimulation of ß-catenin-responsive transcription. J. Virol. 79:5006-5016.[Abstract/Free Full Text]
  39. Sugamura, K., M. Fujii, M. Kannagi, M. Sakitani, M. Takeuchi, and Y. Hinuma.1984 . Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int. J. Cancer 34:221-228.[Medline]
  40. Tanaka, Y., A. Yoshida, Y. Takayama, H. Tsujimoto, A. Tsujimoto, M. Hayami, and H. Tozawa. 1990. Heterogeneity of antigen molecules recognized by anti-tax1 monoclonal antibody Lt-4 in cell lines bearing human T cell leukemia virus type I and related retroviruses.Jpn. J. Cancer Res. 81:225-231.[CrossRef][Medline]
  41. Yamada, Y., M. Tomonaga, H. Fukuda, S. Hanada, A. Utsunomiya, M. Tara, M. Sano, S. Ikeda, K. Takatsuki, M. Kozuru, K. Araki, F. Kawano, M. Niimi, K. Tobinai, T. Hotta, and M. Shimoyama. 2001. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group study 9303. Br. J. Haematol. 113:375-382.[CrossRef][Medline]
  42. Yang, Y., S. Takeuchi, K. Tsukasaki, Y. Yamada, T. Hata, N. Mori, A. Fukushima, H. Seo, H. P. Koeffler, and H. Taguchi.2005 . Methylation analysis of the adenomatous polyposis coli (APC) gene in adult T-cell leukemia/lymphoma. Leuk. Res. 29:47-51.[CrossRef][Medline]
  43. Yoshida, M., I. Miyoshi, and Y. Hinuma. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA 79:2031-2035.[Abstract/Free Full Text]

Journal of Virology, November 2006, p. 10497-10505, Vol. 80, No. 21
0022-538X/06/$08.00+0     doi:10.1128/JVI.00739-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.00739-06v1
80/21/10497    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomita, M.
Right arrow Articles by Mori, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomita, M.
Right arrow Articles by Mori, N.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS